Shop by Product Category
Purchase Assistance
Join Mail List

We Accept: 
Catalog

Product Catalog# Quantity Unit Price Buy
beta-Catenin (C18) Antibody DB077 0.200 mg/ml $190.00

Datasheet 
Datasheet 

For technical service please call (800) 595 1994
Product Info
Background The multifunctional beta-catenin protein was originally identified through its association with the cadherin class of cell adhesion proteins (1&2). It was later found to be an integral part of signal transduction pathways and the best studied is the Wnt/beta-catenin pathway (3). Wnt signaling inhibits the degradation of beta-catenin and as a result beta-catenin becomes transcriptionally active (3-5). The deregulation of Wnt signaling leads to the accumulation of beta-catenin, allowing it to become transcriptionally active for a number of genes. Many of these genes are associated with cancer, such as colorectal cancer and melanomas (3&4). 
Origin beta-catenin (C18) is provided as an affinity purified rabbit polyclonal antibody, raised against a peptide mapping to the carboxy terminal domain of human beta-catenin. 
Product Details Each vial contains 200 g/ml of affinity purified rabbit IgG, beta-catenin (C18) DB077, in 1 ml PBS containing 0.1 % sodium azide and 0.2% gelatin. 
Competition Studies A blocking peptide is also available, DB077P, for use in competition studies. Each vial contains 0.100 mg of peptide in 0.5 ml PBS with 0.1% sodium azide and 100 mg BSA. 
Form 200 g/ml rabbit polyclonal IgG in 1 ml PBS containing 0.1 % sodium azide and 0.2% gelatin. 
Immunogen Synthetic peptide mapping to the carboxy terminal domain of human beta-catenin. 
Specificity beta-catenin (C18) is recommended to detect mouse, rat and human beta-catenin 
Use
Western blot anlaysis of beta-catenin expression in A431 whole cell lysates. 
Storage Store this product at 4 C, do not freeze. The product is stable for one year from the date of shipment. 
References 1. Hinck L, Nathke IS, Papkoff J, Nelson WJ. 1994. ?-catenin: a common target for the regulation of cell adhesion by Wnt-1 and Src signaling pathways. Trends Biochem Sci. 19(12):538-542.
2. Bullions LC, Levine AJ. 1998. The role of ?-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol. 10(1):81-87.
3. Moon RT, Bowerman B, Boutros M, Perrimon N. 2002. The promise and perils of Wnt signaling through ?-catenin. Science 296(5573):1644-1646.
4. Li H, Pamukcu R, Thompson WJ. 2002. ?-catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther. (6):621-625.
5. Hecht A, Kemler R. 2000. Curbing the nuclear activities of ?-catenin. Control over Wnt target gene expression. EMBO 1(1):24-28.
 

For Technical service please call +1-800-595-1994
Delta Biolabs+1-408-846-6650 • fax:+1-408-846-6645 • Copyright © 2001.Allrights reserved.
Powered by Corezon





Apoptosis/Tumor Suppressor Genes| Cell Adhesion| Cell Cycle| Controls| Fusion Protein/Epitope Tags| Growth Factors| Membrane Receptors
Protein Kinases| Secondary Antibodies| Signaling Intermediates| Transcription Regulation